CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Regulatory Non-interventional Study to Monitor the Safety and Efficacy of JARDIANCE® (Empagliflozin 10 mg) in Korean Patients With Chronic Kidney Disease (CKD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06287073
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-24T00:04:43.114102+00:00
Published At: 2026-06-23T00:00:00+00:00
Record Updated At: 2026-06-23
Results Posted At: 2026-06-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Kidney Disease, Chronic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-23"
protocolSection.identificationModule.nctId: "NCT06287073"
protocolSection.identificationModule.officialTitle: "A Regulatory Non-interventional Study to Monitor the Safety and Efficacy of JARDIANCE\u00ae (Empagliflozin 10 mg) in Korean Patients With Chronic Kidney Disease (CKD)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-06-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.